These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6333056)

  • 41. Pharmacological treatment of portal hypertension.
    Patch D; Burroughs AK
    Prog Liver Dis; 1995; 13():269-92. PubMed ID: 9224506
    [No Abstract]   [Full Text] [Related]  

  • 42. Terlipressin-related acute myocardial infarction: a case report and literature review.
    Lee MY; Chu CS; Lee KT; Lee HC; Su HM; Cheng KH; Sheu SH; Lai WT
    Kaohsiung J Med Sci; 2004 Dec; 20(12):604-8. PubMed ID: 15696791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Drug treatment of bleeding esophageal varices. Acute therapy and prevention of recurrence].
    Maier KP
    Dtsch Med Wochenschr; 1986 Feb; 111(8):306-13. PubMed ID: 2868875
    [No Abstract]   [Full Text] [Related]  

  • 44. Terlipressin-induced severe left and right ventricular dysfunction in patient presented with upper gastrointestinal bleeding: case report and literature review.
    Elzouki AN; El-Menyar A; Ahmed E; Elbadri ME; Imam YZ; Gurbanna BA
    Am J Emerg Med; 2010 May; 28(4):540.e1-6. PubMed ID: 20466263
    [No Abstract]   [Full Text] [Related]  

  • 45. Best evidence topic report. Terlipressin or somatostatin for the treatment of bleeding oesophageal varices.
    Boyd R; Butler J
    Emerg Med J; 2005 Jun; 22(6):433-4. PubMed ID: 15911952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.
    Silvain C; Carpentier S; Sautereau D; Czernichow B; Métreau JM; Fort E; Ingrand P; Boyer J; Pillegand B; Doffël M
    Hepatology; 1993 Jul; 18(1):61-5. PubMed ID: 8325622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapy of bleeding esophageal varices. Attempt at a position statement].
    Schröder R
    Schweiz Med Wochenschr; 1986 May; 116(22):726-33. PubMed ID: 3523744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy and mode of action of vasopressin in the treatment of digestive hemorrhages caused by rupture of esophageal or gastric varices].
    Bernard B; Valla D
    Gastroenterol Clin Biol; 1994; 18(8-9):751-60. PubMed ID: 7875446
    [No Abstract]   [Full Text] [Related]  

  • 49. Hyponatremia in patients treated with terlipressin: mechanisms and implications for clinical practice.
    Krag A; Møller S; Bendtsen F
    Hepatology; 2011 Jan; 53(1):368-9; author reply 369-70. PubMed ID: 21254188
    [No Abstract]   [Full Text] [Related]  

  • 50. Approach to the management of bleeding esophageal varices: role of somatostatin.
    Avgerinos A
    Digestion; 1998; 59 Suppl 1():1-22. PubMed ID: 9603441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver.
    Badruddin AH; Rasool G; Chaudhry MA
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):755-9. PubMed ID: 17125633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyponatraemia induced by terlipressin: a case report and literature review.
    Huang Y; Wang M; Wang J
    J Clin Pharm Ther; 2015 Dec; 40(6):626-8. PubMed ID: 26573870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No mortality difference following treatment with terlipressin or somatostatin in cirrhotic patients with gastric variceal hemorrhage.
    Hung TH; Tsai CC; TsenK GC; Hsieh YH; Tseng CW
    Saudi J Gastroenterol; 2016; 22(3):220-5. PubMed ID: 27184641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug therapy of hemorrhage in esophageal and gastric varices: role of vasoactive drugs].
    Pulanić R
    Lijec Vjesn; 2000; 122(11-12):276-83. PubMed ID: 11291271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study.
    Walker S; Kreichgauer HP; Bode JC
    Z Gastroenterol; 1996 Oct; 34(10):692-8. PubMed ID: 8921578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Action of the triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices.
    Vosmík J; Jedlicka K; Mulder JL; Cort JH
    Gastroenterology; 1977 Apr; 72(4 Pt 1):605-9. PubMed ID: 300062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Drip infusion method of octapressin in the control of bleeding from esophageal varices (author's transl)].
    Ukida M; Iwahara S; Shimada Y; Ishikawa Y
    Nihon Shokakibyo Gakkai Zasshi; 1980 Mar; 77(3):445-50. PubMed ID: 6966702
    [No Abstract]   [Full Text] [Related]  

  • 58. [Vasoconstrictive Therapies for Bleeding Esophageal Varices and their Mechanisms of Action].
    Döhler KD; Walker S; Mentz P; Forssmann K; Staritz M
    Z Gastroenterol; 2003 Oct; 41(10):1001-16. PubMed ID: 14562199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hemorrhaging esophageal varices treated by Mansel solution instead of the Sengstaken-Blakemore tube].
    Wang XL
    Zhonghua Hu Li Za Zhi; 1987 May; 22(5):200, 228. PubMed ID: 3499239
    [No Abstract]   [Full Text] [Related]  

  • 60. Terlipressin-induced metabolic acidosis.
    Foresti V; Parisio E; Ungaro A; De Filippi G; Confalonieri F
    Recenti Prog Med; 1991 Apr; 82(4):240-1. PubMed ID: 1857846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.